RecruitingNot ApplicableNCT07318038

The Use of Rhythmic Light Therapy in Mild Cognitive Impairment


Sponsor

Icahn School of Medicine at Mount Sinai

Enrollment

20 participants

Start Date

Dec 8, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

In this within-subjects, crossover study, participants will undergo Electroencephalogram (EEG) recordings before, during, and after each of three 1-hour sessions. All participants will experience all three conditions: (1) dual-frequency visual (10 and 40 Hz), (2) single-frequency visual (40 Hz), and (3) non-rhythmic stimulation. EEG spectral power and amplitude coupling will be analyzed to determine whether stimulation-induced increases in alpha-gamma neural synchrony translate to improvements in cognitive performance.


Eligibility

Min Age: 55 YearsMax Age: 80 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called Flickering Light for people with mild cognitive impairment. The study is currently recruiting participants at 1 location. People eligible for this study include aged 55 Years to 80 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEFlickering Light

Red Flickering Light programed to three different visual stimulations


Locations(1)

Icahn School of Medicine at Mount Sinai

New York, New York, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07318038


Related Trials